Search

Your search keyword '"Drabek, Dubravka"' showing total 193 results

Search Constraints

Start Over You searched for: Author "Drabek, Dubravka" Remove constraint Author: "Drabek, Dubravka"
193 results on '"Drabek, Dubravka"'

Search Results

2. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

6. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

8. Neutralizing Antibodies Reveal Cryptic Vulnerabilities and Interdomain Crosstalk in the Porcine Deltacoronavirus Spike

9. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

10. Filamentous Fungus-Produced Human Monoclonal Antibody Provides SARS-CoV-2 Protection in Hamster and Non-Human Primate Models

14. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern

15. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

17. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

18. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

19. An anti-CTLA-4 heavy chain–only antibody with enhanced T reg depletion shows excellent preclinical efficacy and safety profile

20. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern

21. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

22. Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes

23. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern

24. An anti-CTLA-4 heavy chain-only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile

25. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants

26. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants

30. An anti-CTLA-4 heavy chain-only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile.

31. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

32. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

34. A human monoclonal antibody blocking SARS-CoV-2 infection

35. Multimeric single-domain antibody complexes protect against bunyavirus infections

36. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein

38. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein

39. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

40. Multimeric single-domain antibody complexes protect against bunyavirus infections

41. Author response: Multimeric single-domain antibody complexes protect against bunyavirus infections

42. A human monoclonal antibody blocking SARS-CoV-2 infection

43. Protective human monoclonal antibodies targeting different stages of MERS coronavirus entry

44. Heavy-chain-only antibodies for protection against MERS-CoV

46. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

47. Towards a solution to MERS: Protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

48. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

50. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection

Catalog

Books, media, physical & digital resources